| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2024 ( Subtotal = $1,895,255 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AI143690 | Biogenesis and Function of Streptococcus Pyogenes Cell Wall | 000 | 5 | NIH | 10/26/2023 | $344,250 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI173735 | Addressing genetic tractability and species-specific infection biology in Chlamydia pneumoniae | 000 | 2 | NIH | 10/23/2023 | $172,125 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01CA175105 | Targeting Translation Dependence in Colorectal Cancer Progression | 000 | 10 | NIH | 11/21/2023 | $327,038 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI169231 | Function of the type 7 secretion system in Group B Streptococcus | 000 | 2 | NIH | 10/24/2023 | $175,989 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AG077495 | Drug repurposing for Alzheimer?s disease-related inflammation caused by a TBI | 000 | 2 | NIH | 11/29/2023 | $172,125 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AR073906 | Epigenetic control of muscle stem cell function by PASK-Wdr5 signaling | 000 | 6 | NIH | 12/4/2023 | $302,882 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13AG081016 | Dysphagia: In Search of a Unified Definition for the Aging Population | 000 | 2 | NIH | 11/16/2023 | $45,657 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG066724 | Novel gastrocnemius muscle characteristics in peripheral artery disease patients associated with impaired functional performance | 000 | 4 | NIH | 11/16/2023 | $282,711 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31MH132194 | The Experience and Regulation of Posttraumatic Shame among Women with Histories of Interpersonal Trauma | 000 | 2 | NIH | 11/15/2023 | $47,694 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES033767 | Phthalate-Induced Dysregulation of Prostaglandin and Angiogenic Function During Ovulation in Women | 000 | 3 | NIH | 10/23/2023 | $439,396 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES032396 | A university-community partnership to reduce exposure to disinfection byproducts in Appalachia | 000 | 4 | NIH | 11/3/2023 | $484,636 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES030380 | Radon on the RADAR | 000 | 5 | NIH | 12/5/2023 | $516,698 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01EB028792 | Perioperative Diffuse Optical Imaging of Tissue Blood Flow and Oxygenation for Optimization of Mastectomy Skin Flap Viability | 000 | 4 | NIH | 11/30/2023 | $91,824 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00HL145117 | Macrophage Pyroptosis in Abdominal Aortic Aneurysm | 000 | 5 | NIH | 11/14/2023 | $249,000 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R33DC019602 | Hearing Healthcare Assessment in Rural Communities (HHARC) | 001 | 3 | NIH | 10/27/2023 | $29,645 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R25ES027684 | Summer Research in Environmental Health Sciences | 000 | 7 | NIH | 10/23/2023 | $135,000 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21NS135089 | Cannabidiol (CBD) as a Potential Therapeutic for Experimental Subarachnoid Hemorrhage | 000 | 1 | NIH | 12/5/2023 | $229,500 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K23DK128562 | Classical and Alternative Renin-Angiotensin System Dysregulation in Sepsis-Associated AKI: A Reverse Translation Approach | 000 | 3 | NIH | 11/21/2023 | $157,563 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI180274 | Molecular mechanisms of Helicobacter pylori trans-kingdom DNA conjugation | 000 | 1 | NIH | 11/22/2023 | $192,814 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13OH012359 | SouthON Conference Grant | 00 | 3 | CDC | 12/1/2023 | $20,000 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13AI129382 | Autumn Immunology Conference | 000 | 6 | NIH | 10/20/2023 | $18,000 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI176298 | A Randomized Clinical Trial of Continuous vs. Intermittent Infusion Vancomycin: Effects on Measured GFR and Kidney Injury Biomarkers | 000 | 2 | NIH | 12/7/2023 | $177,113 |
| 2024 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG080589 | APOE Allele Switching as a Therapeutic Approach for Alzheimer's Disease | 000 | 2 | NIH | 11/29/2023 | $578,038 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K23DE031807 | Initial Evidence for a Brief Psychological Telehealth Intervention for Patients with Chronic Masticatory Muscle Pain | 000 | 1 | NIH | 10/17/2023 | $0 |
| 2024 | 2023 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU17CE010182 | Kentucky Advancing Violence Epidemiology In Real-Time | 01 | 1 | CDC | 10/18/2023 | $0 |
| 2024 | 2023 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU17CE010182 | Kentucky Advancing Violence Epidemiology In Real-Time | 01 | 1 | CDC | 10/18/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U24GM146576 | University of Kentucky SuRE Resource Center | 000 | 2 | NIH | 11/14/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | U01DA051377 | Development of Agents for Synthetic Opioid Overdose | 000 | 3 | NIH | 10/12/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS116990 | Elucidating the role of placental growth factor in diffuse white matter disease | 000 | 4 | NIH | 11/28/2023 | -$482,202 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T9952106 | Value-Based Medical Student Education Training Program | 01 | 1 | HRSA | 11/14/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T0830179 | Scholarships for Disadvantaged Students | 02 | 8 | HRSA | 11/29/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | H9500110 | STATE OFFICE OF RURAL HEALTH | 02 | 33 | HRSA | 12/6/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | H9500110 | STATE OFFICE OF RURAL HEALTH | 01 | 33 | HRSA | 10/2/2023 | $0 |
| 2024 | 2023 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T42OH010278 | OCCUPATIONAL SAFETY AND HEALTH EDUCATION AND RESEARCH CENTERS (T42) | 03 | 12 | CDC | 11/1/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | H3H00046 | SMALL RURAL HOSPITAL IMPROVEMENT GRANT PROGRAM | 02 | 22 | HRSA | 11/17/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AA030308 | Sex and Sex Hormone Factors Influencing Acute Alcohol Effects on Sleep Physiology | 000 | 1 | NIH | 10/25/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | H3G45783 | Flex Rural Veterans Health Access Program | 01 | 2 | HRSA | 11/1/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R35HL150818 | Platelet Exocytosis and Endocytosis in Thrombosis and Immunity | 000 | 4 | NIH | 11/6/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P42ES007380 | Nutrition and Superfund Chemical Toxicity | 000 | 25 | NIH | 11/16/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R33DC019602 | Hearing Healthcare Assessment in Rural Communities (HHARC) | 000 | 3 | NIH | 10/27/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P42ES007380 | Nutrition and Superfund Chemical Toxicity | 000 | 25 | NIH | 11/16/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DE033318 | Understanding the Association between Sublingual Buprenorphine and Oral Health Outcomes | 000 | 1 | NIH | 11/22/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P30CA177558 | University of Kentucky Markey Cancer Center ? Cancer Center Support Grant | 001 | 11 | NIH | 11/13/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DE033318 | Understanding the Association between Sublingual Buprenorphine and Oral Health Outcomes | 000 | 1 | NIH | 11/22/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P20GM121327 | University of Kentucky Center for Cancer Metabolism | 000 | 7 | NIH | 10/27/2023 | $0 |
| 2024 | 2023 | University of Kentucky Research Foundation, The | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | NU17CE010186 | Overdose Data to Action | 01 | 1 | CDC | 10/20/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AR078447 | Magnetic nanocomplexes-induced immunomodulation for fracture healing | 000 | 2 | NIH | 12/6/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | UG1DA050069 | Kentucky Women's Justice Community Opioid Innovation Network (WJCOIN) | 000 | 5 | NIH | 10/23/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13OH012359 | SouthON Conference Grant | 00 | 3 | CDC | 12/1/2023 | $0 |
|